YTHDF3 Modulates EGFR/ATK/ERK/p21 Signaling Axis to Promote Cancer Progression and Osimertinib Resistance of Glioblastoma CellsHsin-Hao Lee(Taipei Medical University Hospital), Hsiang‐Cheng Chi(China Medical University)Anticancer ResearchNovember 29, 202310.21873/anticanres.16751Cited by 6SaveCiteExport RISWatch citationsRelated PapersChemotherapy resistance and metastasis-promoting effects of thyroid hormone in hepatocarcinoma cells are mediated by suppression of FoxO1 and Bim pathway|Cell Death and Disease|2016|46